| 2026-04-02 |
SCHEDULE 13D/A |
BridgeBio Pharma, Inc. BBIO |
6.10% |
11,842,434 |
view → |
| 2025-07-01 |
SCHEDULE |
BridgeBio Pharma, Inc. BBIO |
9.80% |
18,602,920 |
view → |
| 2025-01-31 |
SCHEDULE |
BridgeBio Pharma, Inc. BBIO |
11.70% |
22,055,375 |
view → |
| 2023-09-22 |
SC |
Cazoo Group Ltd |
— |
— |
view → |
| 2023-07-20 |
SC |
BridgeBio Pharma, Inc. BBIO |
— |
— |
view → |
| 2023-04-27 |
SC |
Cazoo Group Ltd |
— |
— |
view → |
| 2023-02-27 |
SC |
Cazoo Group Ltd |
— |
— |
view → |
| 2022-03-04 |
SC |
Ginkgo Bioworks Holdings, Inc. DNABW |
— |
— |
view → |
| 2021-10-01 |
SC |
Ginkgo Bioworks Holdings, Inc. DNABW |
— |
— |
view → |
| 2019-07-12 |
SC |
Arbutus Biopharma Corp ABUS |
— |
— |
view → |
| 2019-07-12 |
SC |
Axovant Gene Therapies Ltd. |
— |
— |
view → |
| 2019-07-12 |
SC |
Urovant Sciences Ltd. |
— |
— |
view → |
| 2019-07-12 |
SC |
Myovant Sciences Ltd. |
— |
— |
view → |
| 2019-03-19 |
SC |
Axovant Sciences Ltd. |
— |
— |
view → |
| 2019-01-03 |
SC |
Axovant Sciences Ltd. |
— |
— |
view → |
| 2019-01-03 |
SC |
Urovant Sciences Ltd. |
— |
— |
view → |
| 2019-01-03 |
SC |
Arbutus Biopharma Corp ABUS |
— |
— |
view → |
| 2018-01-16 |
SC |
Arbutus Biopharma Corp ABUS |
— |
— |
view → |